Correlation between Nottingham Prognostic Index and Adjuvant! Online Prognostic tools in patients with early-stage breast cancer in Mid-Western ireland

Clinical Breast Cancer

Volumn 13, Issue 4, 2013, Pages 233-238

  Quintyne, Keith Ian ^a,b   Woulfe, Bernie ^a,c   Coffey, John C ^a,b   Gupta, Rajnish K ^a,c  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b UNIVERSITY OF LIMERICK   (Ireland)

^c UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Adjuvant! Online; Early stage breast cancer; Nottingham Prognostic Index; Prognostic tools

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL;

ADJUVANT ONLINE PROGNOSTIC TOOL; ADULT; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; CORRELATIONAL STUDY; DISEASE SEVERITY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FOLLOW UP; HUMAN; IRELAND; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOTTINGHAM PROGNOSTIC INDEX; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; REVIEW;

ADJUVANT! ONLINE; EARLY-STAGE BREAST CANCER; NOTTINGHAM PROGNOSTIC INDEX; PROGNOSTIC TOOLS;

ADJUVANTS, PHARMACEUTIC; BREAST NEOPLASMS; FEMALE; HUMANS; IRELAND; KAPLAN-MEIER ESTIMATE; NEOPLASM STAGING; PROGNOSIS;

EID: 84884677076     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2013.02.011     Document Type: Review

References (21)

1. Blamey RW, Ellis IO, Pinder SE, et al. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer 2007;43:1548-55.
2. Quintyne KI, Woulfe B, Gupta RK. Retrospective application of Nottingham Prognostic Index (NPI) and Adjuvant! Online tool in newly diagnosed patients with early stage breast cancer in mid-western Ireland. J Clin Oncol 2010;28:15s (Suppl; abstr 6139).
3. Campbell HE, Gray AM, Harris AL, et al. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK. Br J Cancer 2010;103:776-86.
4. Blamey RW, Davies CJ, Elston CW, et al. Prognostic factors in breast cancer-the formation of a Prognostic Index. Clin Oncol 1979;5:227-36.
5. Haybittle JL, Blamey RW, Elston CW, et al. A prognostic Index in primary breast cancer. Br J Cancer 1982;45:361-6.
6. Galea MH, Blamey RW, Elston CE, et al. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992;22:207-19.
7. Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001;19:980-91.
8. Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005;23:2716-25.
9. Adjuvant! Online. Adjuvant! Breast Cancer Files. 2005. Available at: https://www.adjuvantonline.com/breastnew.jsp. Accessed August 1, 2012.
10. Moons K G M, Royston P, Vergouwe Y, et al. Prognosis and prognostic research: what, why, and how? BMJ 2009;338:1317-20.
11. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumour marker prognostic studies (REMARK). Br J Cancer 2005;93:387-91.
12. Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006;144:201-9.
13. Balakrishnan A, Haysom SA, Ravichandran D. Adjuvant! Online does not significantly influence adjuvant chemotherapy decisions of breast cancer multidisciplinary team (MDT): a prospective study. Ann Oncol 2011;22:1461-2.
14. Yu K, Lee CH, Tan PH, et al. A molecular signature ofthe Nottingham Prognostic Index in breast cancer. Cancer Res 2004;64:2962-8.
15. Price RK, Morgan CZ, Roe T, et al. Choosing chemotherapy: who says 'yes please'? Cancer Res 2009;69:1 (Suppl; abstr 5091).
16. Blamey RW, Hornmark-Stenstam B, Ball G, et al. ONCOPOOL-a European database for 16 944 cases of breast cancer. Eur J Cancer 2010;46:56-71.
17. Gribbin J, Dewis R. Adjuvant! Online: a review ofevidence concerning its validity, and other considerations in relating to use in the NHS. NICE Clinical guidelines (2009), Number 80, Appendix 1. Available at: http://www.ncbi.nlm.nih. gov/books/NKB11643/pdf/TOC.pdf. Accessed February 1, 2012.
18. Howladen N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review (2011), 1975-2008, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975-2008/. Accessed February 1, 2012.
19. Bowen RL, Duffy SW, Ryan DA, et al. Early onset breast cancer in a group of Black British women. Br J Cancer 2008;98:277-81.
20. Ungat AM, Xie L, Morriss J, et al. Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer 2004;90:1138-43.
21. Aebi S, Davidson T, Gruber G, et al. Primary breast cancer: ESMO clinical practise guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011;22:vii12-vi24.